Idexx Laboratories stock was rising sharply Monday, even as the S&P 500 and major indexes remained in the red. The Dow Jones ...

BofA analyst Michael Ryskin raised the firm’s price target on Idexx Laboratories (IDXX) to $535 from $475 and keeps a Neutral rating on the ...

IDEXX (IDXX) stock jumped 12% in early trading Monday after the pet healthcare company issued a Q4 earnings report and 2025 ...

Stocks were falling Monday but came off sharp lows as President Donald Trump’s delay to tariffs on Mexico for a month had ...

Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments.

Barclays raised the firm’s price target on Idexx Laboratories (IDXX) to $520 from $481 and keeps an Overweight rating on the shares. The ...

IDEXX Laboratories beat Wall Street estimates for fourth-quarter revenue and profit on Monday, helped by strong demand for its veterinary diagnostic services despite persistent weakness in visits to ...

IDEXX Laboratories ( IDXX) was the best-performing stock in the S&P 500 after the provider of veterinary healthcare products ...

IDEXX Laboratories, Inc. ( NASDAQ: IDXX) Q4 2024 Earnings Conference Call February 3, 2025 8:30 AM ET Brian McKeon - Chief Financial Officer Andrew Emerson - Senior Vice President, Corporate & ...

IDEXX Laboratories, Inc.’s IDXX share price has surged by 11.13%, which has investors questioning if this is right time to ...

IDEXX Laboratories shared earlier this month the launch of IDEXX Cancer Dx, a diagnostic panel with early detection of ...

Idexx forecast revenue between $4.06 billion and $4.17 billion in 2025, in line with analysts' estimates of $4.14 billion. The company also guided for earnings per share in the range of $11.74 and $12 ...